Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds

Area of Science:

• Mitochondrial biology
• Cancer research
• Natural product chemistry

Background:

• Mitochondria are crucial for cellular metabolism, redox balance, and cell death.
• Cancer cells often display mitochondrial dysfunction and altered metabolism.
• Targeting mitochondria presents a promising strategy for cancer therapy.

Purpose of the Study:

• To review natural compounds (mitocans) that selectively kill cancer cells with mitochondrial dysfunction.
• To discuss the mechanisms of action and therapeutic potential of these mitocans.
• To explore future perspectives on mitochondrial-targeted cancer therapy, focusing on selectivity.

Main Methods:

• Literature review of natural compounds with anticancer activity targeting mitochondria.
• Analysis of studies investigating the mechanisms of action of these compounds in vitro and in vivo.
• Discussion of therapeutic selectivity and biochemical basis for targeted cancer treatment.

Main Results:

• Several natural compounds demonstrate preferential killing of cancer cells with mitochondrial defects.
• These compounds act through various mechanisms that disrupt mitochondrial function.
• The review excludes mitocans that have been recently and comprehensively reviewed.

Conclusions:

• Natural compounds targeting mitochondrial dysfunction offer a promising avenue for selective cancer therapy.
• Understanding the biochemical basis of selectivity is crucial for developing effective mitocan-based treatments.
• Further research into these natural compounds could lead to novel therapeutic strategies for cancer.